In summary, the results obtained in the present study demonstrated that IL-17A and MMP-9 were expressed in the granuloma of different mycetoma causative agents and that the expression of IL-17A was more extensively in larger leasions and lesions with a longer disease duration. The gene discussed is MMP9; the disease is Granuloma.